365betÓéÀÖ

Clinical evaluation of the efficacy of Shvitrahara kashaya and lepa in vitiligo

| Posted in: Science

Journal name: AYU (Journal of Research in Ayurveda)
Original article title: Clinical evaluation of the efficacy of Shvitrahara kashaya and lepa in vitiligo
AYU is an internationally recognized quarterly journal dedicated to advancing research in Ayurveda. The journal covers a wide range of topics, including clinical and pharmacological research in Ayurveda's eight branches, herbal remedies, phytochemistry, and ethnomedicine.

Original source:

This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.

Author(s):

Ajay Dhanik
N. Sujatha
N. P. Rai


AYU (Journal of Research in Ayurveda):

(An International Quarterly Journal of Research in Ayurveda)

Full text available for: Clinical evaluation of the efficacy of Shvitrahara kashaya and lepa in vitiligo

Year: 2011 | Doi: 10.4103/0974-8520.85731

Copyright (license): CC BY-NC-SA 4.0


Download the PDF file of the original publication


Summary of article contents:

Vitiligo is a progressive, idiopathic, pigmentation disorder of the skin, characterized by hypopigmented white lesions. PUVA therapy is the treatment of choice in the modern system of medicine. In Ayurveda, Shvitra or Kilasa is the term employed to describe hypopigmentation disorders of the skin. Shvitra is caused by various dietic and behavioral factors which aggravate the tridoshas, especially the Kapha dosha vitiating the Meda dhatu. Many Ayurvedic drugs are well known for the regeneration of melanocytes, among which Bakuchi is one. The present study was planned to study its efficacy in the regeneration of melanocytes. The outcome of treatment in 50 cases of Shvitra vis-à-vis vitiligo receiving Shvitrahara kashaya and Shvitrahara lepa was analyzed and compared. Group I (n = 25) patients were treated with Shvitrahara kashaya and Shvitrahara lepa; Group II (n = 15) patients received Shvitrahara lepa only; and the remaining 10 patients of Group III used both (Western medicine) oral psoralens and UV-A therapy. Assessment was done after 6 months with bi-monthly follow-ups. Out of 25 cases in Group I, 17 showed 80% improvement (t = 7.65; P < 0.01) in the surface area, number of lesions, pigmentation and associated symptoms like itching; out of 15 patients in Group II, 10 showed partial repigmentation, i.e. 50% (t = 5.72; P < 0.01) response was observed. In Group III, 90% response (t = 6.14; P < 0.001) in repigmentation and number of lesions as well was noted but eight patients developed adverse effects like sunburn, severe itching and gastric upset on taking oral psoralen. On the basis of results and observations, it can be concluded that Ayurvedic formulation containing Bakuchi is efficacious and has no untoward effects when compared to oral psoralens and UV-A therapy. Keywords: Bakuchi, Haridra, haritala, psoralens, Shvitra, vitiligo

Other Science Concepts:

[back to top]

Discover the significance of concepts within the article: �Clinical evaluation of the efficacy of Shvitrahara kashaya and lepa in vitiligo�. Further sources in the context of Science might help you critically compare this page with similair documents:

Tridosha, Medadhatu, Haratala, Kaphadosha, Adverse effect, Clinical trial, Safety profile, Hepatoprotective properties, Ayurvedic Drug, PUVA therapy, Immune modulation, Ethics approval, Repigmentation, Krichra Sadhya.

Let's grow together!

I humbly request your help to keep doing what I do best: provide the world with unbiased sources, definitions and images. Your donation direclty influences the quality and quantity of knowledge, wisdom and spiritual insight the world is exposed to.

Let's make the world a better place together!

Like what you read? Help to become even better: